[HTML][HTML] Procalcitonin levels in COVID-19 patients are strongly associated with mortality and ICU acceptance in an underserved, inner city population

T Feng, A James, K Doumlele, S White, W Twardzik… - Medicina, 2021 - mdpi.com
Background and Objectives: This study aimed to identify demographic and clinical factors at
the time of critical care consultation associated with mortality or intensive care unit …

Investigation of subsequent and co-infections associated with SARS-CoV-2 (COVID-19) in hospitalized patients

MP Crotty, R Akins, A Nguyen, R Slika… - medRxiv, 2020 - medrxiv.org
Background SARS-CoV-2 has drastically affected healthcare globally and causes COVID-
19, a disease that is associated with substantial morbidity and mortality. We aim to describe …

[HTML][HTML] A high C-reactive protein/procalcitonin ratio predicts Mycoplasma pneumoniae infection

OL Neeser, T Vukajlovic, L Felder, S Haubitz… - Clinical Chemistry and …, 2019 - degruyter.com
Abstract Background Discriminating Mycoplasma pneumoniae (MP) from Streptococcus
pneumoniae (SP) and viral etiologies of community-acquired pneumonia (CAP) is …

Biomarcadores biológicos en las enfermedades respiratorias

F García-Río, B Alcázar-Navarrete… - Archivos de …, 2022 - Elsevier
En los últimos años la llamada «medicina personalizada o de precisión» ha irrumpido con
fuerza en el manejo de las enfermedades, entre ellas las respiratorias. La posibilidad de …

[HTML][HTML] Biomarkers in community-acquired pneumonia (cardiac and non-cardiac)

R Méndez, I Aldás, R Menéndez - Journal of clinical medicine, 2020 - mdpi.com
Community-acquired pneumonia (CAP) remains the first cause of morbidity and mortality
worldwide due to infection. Several aspects such as severity and host response are related …

[HTML][HTML] Streptococcus pneumoniae and Influenza A Virus Co-Infection Induces Altered Polyubiquitination in A549 Cells

T Sura, V Gering, C Cammann… - Frontiers in cellular …, 2022 - frontiersin.org
Epithelial cells are an important line of defense within the lung. Disruption of the epithelial
barrier by pathogens enables the systemic dissemination of bacteria or viruses within the …

The potential clinical value of pairing procalcitonin and lung ultrasonography to guide antibiotic therapy in patients with community-acquired pneumonia: a narrative …

C Bessat, N Boillat-Blanco… - Expert Review of …, 2023 - Taylor & Francis
Introduction Lower respiratory tract infections (LRTIs) are among the most frequent infections
and are prone to inappropriate antibiotic treatments. This results from a limited accuracy of …

[HTML][HTML] Using precision medicine for the diagnosis and treatment of viral pneumonia

RR Watkins - Advances in Therapy, 2022 - Springer
The COVID-19 pandemic has drawn considerable attention to viral pneumonia from
clinicians, public health authorities, and the general public. With dozens of viruses able to …

Procalcitonin as a biomarker to guide treatments for patients with lower respiratory tract infections

O Saura, CE Luyt - Expert Review of Respiratory Medicine, 2023 - Taylor & Francis
Introduction Lower respiratory tract infections are amongst the main causes for
hospital/intensive care unit admissions and antimicrobial prescriptions. In order to reduce …

C-reactive protein-guided use of procalcitonin in COVID-19

R Houghton, N Moore, R Williams… - JAC-antimicrobial …, 2021 - academic.oup.com
Background A low procalcitonin (PCT) concentration facilitates exclusion of bacterial co-
infections in COVID-19, but high costs associated with PCT measurements preclude …